We’ve got our sights set on some big things this year and beyond.
We’re working on unlocking insights into the scientific history and research potential of siRNA, plasmids, and recombinant proteins to start. Following which, scaling to include additional compounds, cell lines, and tissue banks.
We’re also expanding our AI technology and knowledge graphs to address broader discovery challenges such as patient cohort identification, patent decoding; and perhaps most important, agnostic queries for diseases, pathways, proteins, and genes across all literature to guide experimental design.
You can read about the latest platform features and those in the pipeline on our blog here: https://blog.benchsci.com/tag/benchsci-updates